TrialScope Announces Winners of 2nd Annual Clārus Awards at Clinical Trial Transparency Conference

▤ Summary

CEO Jeff Kozloff kicked off the annual event, emphasizing the importance of clinical trial disclosure and transparency. “At TrialScope, our goal is to change the collective mindset of the industry, shifting the perception of transparency from a regulatory requirement to a strategic advantage.” Keynote speaker was Dr. Deborah Zarin, MRCT Center program director and Harvard Medical School faculty member. Francine Lane, TrialScope Vice President of Global Transparency and Senior Director of Product Management, held an interactive design sprint to guide development of a core disclosure form. Chief Strategy Office Thomas Wicks also shared initial findings from TrialScope’s 2019 Transparency Benchmark and Plain Language Summaries surveys. TrialScope provides proven solutions designed to optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing.

▦ Linked Companies

TrialScope

$10M to $25M